ORG Partners LLC Buys 242 Shares of CME Group Inc. (NASDAQ:CME)

ORG Partners LLC increased its position in shares of CME Group Inc. (NASDAQ:CME) by 201.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 362 shares of the financial services provider’s stock after purchasing an additional 242 shares during the quarter. ORG Partners LLC’s holdings in CME Group were worth $76,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Capital Advisors Ltd. LLC boosted its stake in CME Group by 5.0% in the third quarter. Capital Advisors Ltd. LLC now owns 1,032 shares of the financial services provider’s stock valued at $207,000 after acquiring an additional 49 shares during the last quarter. West Family Investments Inc. lifted its stake in shares of CME Group by 3.4% during the 2nd quarter. West Family Investments Inc. now owns 1,503 shares of the financial services provider’s stock valued at $278,000 after buying an additional 50 shares in the last quarter. Jaffetilchin Investment Partners LLC lifted its stake in shares of CME Group by 1.7% during the 3rd quarter. Jaffetilchin Investment Partners LLC now owns 3,022 shares of the financial services provider’s stock valued at $605,000 after buying an additional 51 shares in the last quarter. Fidelis Capital Partners LLC lifted its stake in shares of CME Group by 3.9% during the 3rd quarter. Fidelis Capital Partners LLC now owns 1,400 shares of the financial services provider’s stock valued at $280,000 after buying an additional 52 shares in the last quarter. Finally, Thrivent Financial for Lutherans lifted its stake in shares of CME Group by 0.3% during the 2nd quarter. Thrivent Financial for Lutherans now owns 15,841 shares of the financial services provider’s stock valued at $3,243,000 after buying an additional 52 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Price Performance

Shares of NASDAQ:CME opened at $206.23 on Tuesday. The company’s fifty day moving average price is $214.01 and its 200-day moving average price is $211.60. The firm has a market capitalization of $74.24 billion, a price-to-earnings ratio of 23.25, a PEG ratio of 5.95 and a beta of 0.49. CME Group Inc. has a one year low of $175.73 and a one year high of $223.80. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The business’s revenue for the quarter was up 19.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.92 EPS. On average, equities research analysts anticipate that CME Group Inc. will post 9.56 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were issued a $1.15 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date was Thursday, March 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.23%. CME Group’s dividend payout ratio is presently 51.86%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CME. Argus upped their price target on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Barclays upped their price target on shares of CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research note on Monday, April 8th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $210.00 price target (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Keefe, Bruyette & Woods restated a “market perform” rating and set a $229.00 price target on shares of CME Group in a research note on Wednesday, April 3rd. Finally, Rosenblatt Securities reaffirmed a “sell” rating and set a $180.00 target price on shares of CME Group in a report on Thursday, January 4th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $215.70.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.